Lidco develops less-invasive heart monitor:
This article was originally published in Clinica
Executive Summary
UK company Lidco has developed a less-invasive technology to provide continuous cardiac output data and direct measurement of left heart performance. The technology is a combination of indicator dilution and arterial pressure waveform analysis. Lidco will sell the system in the US through its sales organisation based in Florida, while Nissho and Sterimed will sell the technique in Japan and Europe respectively. The company believes that around 4 million people in the US would be suitable for the technology and estimates a world market potential of $500 million.